Technology
Health
Pharmaceutical

Ra Pharmaceuticals

$33.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.90 (-2.61%) Today
$0.00 (0.00%) As of 4:28 PM EDT after-hours

Why Robinhood?

You can buy or sell RARX and other stocks, options, ETFs, and crypto commission-free!

About RARX

Ra Pharmaceuticals, Inc. Common Stock, also called Ra Pharmaceuticals, is a clinical stage biopharmaceutical company, which engages in the development of peptide-based drugs for a variety of therapeutic uses. Read More The company's product include RA101495 SC, which is an injection into the tissue under the skin, for the treatment of paroxysmal nocturnal hemoglobinuria. Ra Pharmaceuticals was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.

Employees
72
Headquarters
Cambridge, Massachusetts
Founded
2008
Market Cap
1.42B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
374.47K
High Today
$34.44
Low Today
$32.92
Open Price
$34.40
Volume
341.89K
52 Week High
$34.50
52 Week Low
$8.67

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
2016 IPO
US
North America

RARX Earnings

-$0.67
-$0.60
-$0.52
-$0.45
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.